How should we measure medication adherence in clinical trials and practice?
Jeannie K Lee, Karen A Grace, Terri G Foster, Monica J Crawley, Goldina I Erowele, Hazel J Sun, Phuong T Turner, Lance E Sullenberger, Allen J Taylor
Pharmacy and Cardiology Services, Walter Reed Army Medical Center, Washington, DC, USA
Objective: To determine if simple adherence measures, such as twenty-four hour recall and refill history, are accurate for routine use, compared to more time-consuming measures such as pill counts.
Design: Randomized, double-blind, placebo-controlled trial.
Setting: Walter Reed Army Medical Center, a tertiary medical center in Washington.
Patients: Men and women >30 years old with known coronary heart disease and taking a statin medication.
Intervention: Clinical pharmacists met with patients for adherence assessments.
Main outcome measures: Adherence was measured by pill counts, twenty-four hour recall by patient, and refill history per computer record. Temporal changes in these adherence measures were assessed using general linear models for repeated measures.
Results: Adherence was consistently greater for the experimental agent than for the statin therapy (n = 148). Mean pill count adherence for statin drug was 78.7 ± 25.2% compared to 93.5 ± 11.6% (P < 0.001) for the study agent. Refill history and twenty-four hour recall inaccurately measured adherence when compared to pill counts. Adherence, as determined by pill count, for both experimental (P = 0.029) and statin therapy (P = 0.015) showed significant variability across time in general linear models. Neither refill history nor twenty-four hour recall was sensitive to temporal changes.
Conclusions: Twenty-four hour recall and refill history inaccurately measure medication adherence for both clinical trial and clinical practice pharmacotherapies. Further, these measures are insensitive to changes in adherence. For a single or multiple assessments across time, pill count more accurately measures medication adherence. Pill count should be the standard for monitoring medication adherence for both clinical trials and clinical practice.
Keywords: adherence, hyperlipidemia, niacin, pharmacist, pill count, simvastatin
Readers of this article also read:
Performance in L1 and L2 observed in Arabic-Hebrew bilingual aphasic following brain tumor: A case constitutes double dissociation
Published Date: 2 October 2008
Local anesthetic failure associated with inflammation: verification of the acidosis mechanism and the hypothetic participation of inflammatory peroxynitrite
Takahiro Ueno, Hironori Tsuchiya, Maki Mizogami, Ko Takakura
Published Date: 13 November 2008
Problems and barriers of pain management in the emergency department: Are we ever going to get better?
Sergey M Motov, Abu NGA Khan
Published Date: 9 December 2008
Minoru Yamaoka, Yusuke Ono, Masahiro Takahashi, Ryosuke Doto, et al.
Published Date: 14 April 2009
Eggshell membrane: A possible new natural therapeutic for joint and connective tissue disorders. Results from two open-label human clinical studies
Kevin J Ruff, Dale P DeVore, Michael D Leu, Mark A Robinson
Published Date: 18 May 2009
Eduardo Pimenta, Suzanne Oparil
Published Date: 19 May 2009
Nazem Bassil, Saad Alkaade, John E Morley
Published Date: 11 June 2009
Mannu P, Rinaldi S, Fontani V, Castagna A
Published Date: 15 June 2011
Greek R, Hansen LA, Menache A
Published Date: 6 December 2011
Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects
Vinson JA, Burnham BR, Nagendran MV
Published Date: 18 January 2012